AGER and Gerstmann syndrome: To establish the causal role of the RAGE/NF-κB/Nrf2 pathway in the therapeutic effects of GS, we performed gain/loss-of-function experiments using RAGE overexpression (oe-RAGE) and pharmacological inhibition of Nrf2 with ML385.